Investors can buy low cost index fund if they want to receive the average market return. But across the board there ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc., in collaboration with Asher ...

Amgen laid out $3.7 billion to get its hands on ChemoCentryx and its approved drug Tavneos in August of 2022. At the time, ...

After taking a $50 million hit in a patent lawsuit targeting its leukemia med Blincyto last year, Amgen has convinced a ...

Amgen’s second quarter results outpaced Wall Street’s expectations, with management emphasizing strong demand for its ...

HQH offers a 12.4% yield and trades at a discount, with Berkshire's healthcare move signaling a sector rebound and strong ...

Biotechnology company, Amgen, has announced that it has entered into a definitive agreement to acquire deCODE Genetics, a global leader in human genetics, for US $415 million. The all-cash ...

Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach and tens of thousands of employees belie its humble origins. Founded in 1980 as Applied ...

The awardees were celebrated for their life-bettering products at a banquet in Washington, DC, on Tuesday, Aug. 19 ...

Single Ventricle Heart Disease is a rare congenital heart defect where one of the heart's ventricles is underdeveloped or ...

Singzyme, a Singapore -based biotech startup pioneering next-generation bioconjugation solutions, has been named the winner of the 2025 Golden Ticket Programme in Singapore. The award is part of a ...